ISRCTN66611560
Completed
Not Applicable
A phase IIa clinical trial to demonstrate proof of concept of an experimental pediculicide lotion for the treatment of head lice
EctoPharma Limited (UK)0 sites20 target enrollmentJuly 20, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Head lice infestation
- Sponsor
- EctoPharma Limited (UK)
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients aged four and over
- •2\. Patients who upon examination, are confirmed to have live head lice
- •3\. Patients who give their written informed consent, or if the patient is less than 16 years of age, whose parent/guardian gives written informed consent to participate in the study
- •4\. Patients who will be available for home visits from Medical Entomology Centre (MEC) study team members over the 15 days of the study
Exclusion Criteria
- •1\. Patients with a known sensitivity to any of the ingredients in the product
- •2\. Patients with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long term scalp condition (e.g. psoriasis of the scalp)
- •3\. Patients known to suffer from asthma
- •4\. Patients who have been treated with other head lice products within the last two weeks. There must be a 14\-day gap since treatment for head lice was last used before the patient can be accepted on to this trial.
- •5\. Patients who have bleached hair, or hair that has been colour treated or permanently waved within the last four weeks (wash in/wash out colours are acceptable)
- •6\. Patients who have been treated with the antibiotics co\-trimoxazole, septrin or trimethoprim within the last four weeks, or who are currently taking such a course
- •7\. Pregnant or nursing mothers
- •8\. Patients who have participated in another clinical study within one month before entry to this study
- •9\. Patients who have already participated in this clinical study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A phase IIa clinical trial to demonstrate the proof of concept of an experimental pediculicide lotion for the treatment of head liceEUCTR2005-005512-24-GBEctoPharma Limited20
Completed
Not Applicable
Phase I/II clinical trial of verification for the safety and efficacy of Amitose-Bis-glyceryl ascorbate-containing cream in renal cell carcinoma patients treated by sunitinibRenal cell carcinomaJPRN-UMIN000027209Kobe University Hospital24
Suspended
Phase 2
A phase II randomized clinical trial to determine the effectiveness of goreisan and saireito for lower limb lymphedema in women treated for gynecologic cancerower Limb LymphedemaLymphedemaD008209JPRN-jRCT1041190019Kajiyama Hiroaki40
Completed
Phase 1
A proof-of-concept clinical trial to evaluate the efficacy and safety of combined use of cefadroxil and tyrosine kinase inhibitors in minimal residual disease-positive patients with chronic phase chronic myelogenous leukemiaChronic myelogenous leukemiaJPRN-UMIN000027904Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University.
Active, not recruiting
Not Applicable
ocal treatment of bronchopleural fistula with adilts stem cellsEUCTR2012-000292-16-ESFundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP)